Joubert syndrome in French Canadians and identification of mutations in CEP104

Care4Rare Canada Consortium

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Abstract

Joubert syndrome (JBTS) is a primarily autosomal-recessive disorder characterized by a distinctive mid-hindbrain and cerebellar malformation, oculomotor apraxia, irregular breathing, developmental delay, and ataxia. JBTS is a genetically heterogeneous ciliopathy. We sought to characterize the genetic landscape associated with JBTS in the French Canadian (FC) population. We studied 43 FC JBTS subjects from 35 families by combining targeted and exome sequencing. We identified pathogenic (n = 32 families) or possibly pathogenic (n = 2 families) variants in genes previously associated with JBTS in all of these subjects, except for one. In the latter case, we found a homozygous splice-site mutation (c.735+2T>C) in CEP104. Interestingly, we identified two additional non-FC JBTS subjects with mutations in CEP104; one of these subjects harbors a maternally inherited nonsense mutation (c.496C>T [p.Arg166∗]) and a de novo splice-site mutation (c.2572-2A>G), whereas the other bears a homozygous frameshift mutation (c.1328-1329insT [p.Tyr444fs∗3]) in CEP104. Previous studies have shown that CEP104 moves from the mother centriole to the tip of the primary cilium during ciliogenesis. Knockdown of CEP104 in retinal pigment epithelial (RPE1) cells resulted in severe defects in ciliogenesis. These observations suggest that CEP104 acts early during cilia formation by regulating the conversion of the mother centriole into the cilia basal body. We conclude that disruption of CEP104 causes JBTS. Our study also reveals that the cause of JBTS has been elucidated in the great majority of our FC subjects (33/35 [94%] families), even though JBTS shows substantial locus and allelic heterogeneity in this population.

Original languageEnglish (US)
Pages (from-to)744-753
Number of pages10
JournalAmerican journal of human genetics
Volume97
Issue number5
DOIs
StatePublished - Nov 5 2015

Funding

Foremost, we thank the families who generously contributed their time and materials to this research study. This work was selected for study by the Care4Rare (Enhanced Care for Rare Genetic Diseases in Canada) Canada Consortium Gene Discovery Steering Committee (Kym Boycott [lead; University of Ottawa], Alex MacKenzie [co-lead; University of Ottawa], Jacek Majewski [McGill University], Michael Brudno [University of Toronto], Dennis Bulman [University of Ottawa], and David Dyment [University of Ottawa]) and was funded in part by Genome Canada, the Canadian Institutes of Health Research (CIHR), the Ontario Genomics Institute, the Ontario Research Fund, Genome Quebec, and the Children\u2019s Hospital of Eastern Ontario Foundation. We wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and G\u00E9nome Qu\u00E9bec Innovation Centre in Montreal. We thank Megan T. Cho (GeneDx) for coordinating the exchange of exome sequencing data. This work was funded by the Government of Canada through Genome Canada, the CIHR, G\u00E9nome Qu\u00E9bec, and the Ontario Genomics Institute (OGI-049). J.L.M. is a National Scholar from the Fonds de Recherche du Qu\u00E9bec \u2013 Sant\u00E9 (FRQS). M.S. holds a CIHR clinician-scientist training award. D.L. receives financial support from the FRSQ R\u00E9seau de M\u00E9decine G\u00E9n\u00E9tique Appliqu\u00E9e.

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Joubert syndrome in French Canadians and identification of mutations in CEP104'. Together they form a unique fingerprint.

Cite this